San Diego, Calif.—March 29, 2006—Artes Medical, Inc., a fully-integrated medical technology company focused on the development, manufacture and commercialization of a new category of permanent aesthetic injectable products, today announced that it has raised approximately $50.7 million in a series of private equity financings involving the sale of its Series E Preferred Stock. Since its inception in 1999, the Company has raised approximately $80 million in private equity financings.
